R. N. Sal6atore et al. / Tetrahedron Letters 42 (2001) 1799–1801
1801
H
N
O
Ph
n-BuBr, Cs2CO3, TBAI
DMF, 23 °C, 10 h, 93%
N
O
Ph
O
O
Me
Me
N
18
24
H
N
O
Ph
n-BuBr, Cs2CO3, TBAI
DMF, 23 °C, 6 h, 82%
N
O
Ph
N
O
O
19
25
Scheme 2.
novel protecting group,10 also demonstrated to be prag-
matic. Various heterocyclic amines (11–13) were sub-
jected to similar conditions to produce the desired
alkylation products. However, much to our surprise
and disappointment, lipophilic carbamate 14 and steri-
cally hindered cyclooctyl carbamate 15 were resistant to
alkylations under the developed conditions, and the
unreacted starting materials were recovered.
References
1. Vauthey, I.; Valot, F.; Gozzi, C.; Fache, F.; Lemaire, M.
Tetrahedron Lett. 2000, 41, 6347.
2. Greene, T. W.; Wuts, P. G. M. Protective Groups in
Organic Synthesis, 3rd ed.; J.W. Wiley and Sons: New
York, 1999; pp. 503–550 and references cited therein.
3. Warrass, R.; Weismuller, K.-H.; Jung, G. Tetrahedron
Lett. 1998, 39, 2715.
Next, our attention was directed towards N-alkylation
of aromatic carbamates. As exemplified in Table 2,
carbamates of aniline moieties reacted efficiently, giving
similar results to the aliphatic showcases (entries 1–3).
In addition, pyridine containing carbamates reacted
smoothly to offer the corresponding products in high
yields (e.g. entry 4). Comparatively, regardless of the
introduction of an electron withdrawing substituent,
which would render the carbamate less basic, nitrocar-
bamates (entries 5–7) or acetophenone carbamate 23
reacted expeditiously, affording the desired dialkyl car-
bamates respectively in outstanding yields. In all the
attempted examples, our conditions were highly
chemoselective and efficient, and no side products were
detected whatsoever.
4. (a) Li, Z.; Bitha, P.; Lang, Jr., S. A.; Lin, Y. Biol. Med.
Chem. Lett. 1997, 7, 2909; (b) Bundgaard, H. Drugs
Future 1991, 16, 443.
5. (a) Rafik, C.; Abboud, J. L. M.; Guiheneuf, G. J. Org.
Chem. 1983, 24, 4761; (b) Radeglia, R.; Andersch, J.;
Schroth, W. Z. Naturforsch., Teil. B. 1989, 44, 181.
6. (a) Sheludyakov, V. D. J. Chem. USSR 1972, 42, 357;
(b) Moertl, M.; Knausz, D.; Kolos, Z. S.; Szakacs, L.;
Csakvari, B. J. Organomet. Chem. 1994, 183.
7. Salvatore, R. N.; Nagle, A. S.; Schmidt, S. E.; Jung, K.
W. Org. Lett. 1999, 1, 1893.
8. (a) Salvatore, R. N. Shin, S. I.; Nagle, A. S.; Jung, K. W.
J. Org. Chem. 2001, 66, 1035. For our solid phase car-
bamation protocol, see: (b) Salvatore, R. N.; Flanders,
V. L.; Ha, D.; Jung, K. W. Org. Lett. 2000, 2, 2797.
9. Representative experimental procedure: Under a nitrogen
atmosphere, carbamate 16 (0.11 g, 0.43 mmol) was dis-
solved in anhydrous DMF (5 mL), then Cs2CO3 (0.42 g,
1.29 mmol, 3 equiv.) and TBAI (0.48 g, 1.29 mmol, 3
equiv.) were added to the solution. After stirring for 30
minutes at ambient temperature, BnCl (0.17 g, 1.29
mmol, 3 equiv.) was added into the suspension. The
reaction mixture was stirred for 5 hours, poured into
water, and extracted with EtOAc (3×30 mL). The com-
bined organic layers were washed with water (2×30 mL),
brine (30 mL), and dried over anhydrous sodium sulfate.
Column chromatography (5:1 hexanes:EtOAc) gave the
To demonstrate prospects of mildness and substrate
versatility, N-alkylations were also successful using an
unreactive halide such as 1-bromobutane. As illustrated
in Scheme 2, carbamates 18 and 19 underwent facile
alkylations, implying this technology is compatible with
various alkyl bromides.
In conclusion, an efficient synthetic method was devel-
oped to prepare fully substituted carbamates. The
newly found alkylation conditions were mild and high
yielding to offer a general method with substrate ver-
satility. Furthermore, applications of this protocol to
the synthesis of carbamate peptidomimetics will be
reported in due course.
1
desired carbamate (0.15 g, 98%) as an oil. H NMR (360
MHz, CDCl3) l 1.83 (t, 2 H, J=6.7 Hz), 2.48 (t, 2 H,
J=7.1 Hz), 4.10 (t, 2 H, J= 5.8 Hz), 4.82 (s, 2 H),
7.00–7.27 (m, 15 H). 13C NMR (90 MHz, CDCl3) l 30.51,
31.94, 54.14, 64.93, 125.82, 126.42, 126.83, 127.21, 127.68,
128.31, 128.38, 128.76, 137.98, 141.22, 142.11, 155.73. IR
(thin film) 3389, 3085, 3062, 3028, 2952, 2858, 1948, 1876,
Acknowledgements
We gratefully acknowledge financial supports from the
H. Lee Moffitt Cancer Center & Research Institute and
the American Cancer Society (Institutional Research
Grant c032).
1803, 1702, 1597, 1496, 1404, 1275, 1223 cm−1
.
10. Lipshutz, B. H.; Papa, P.; Keith, J. M. J. Org. Chem.
1999, 64, 3792.
.